ATH
Click for more information
11.1% 0.5¢ alterity therapeutics limited

Research AD biomarkers to routine diagnostics, page-5

  1. m123456
    1,639 Posts.
    lightbulb Created with Sketch. 143
    clock Created with Sketch.
    15/03/21
    11:26
    Post #: 51768287
    ?? Pbt2 is worth way more than 3c or 4c a share. Why would alteriry sell it? I bet it they did it would be straight back into trials for AD and the dog concerns would disappear
    Last edited by m123456: 15/03/21
    ATH Price at posting: 3.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
0.001(11.1%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $4.263K 916.0K

Buyers (Bids)

No. Vol. Price($)
58 69165915 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 38212524 21
View Market Depth
Last trade - 15.11pm 05/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.